Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Acne in Skin of Color: Special Considerations

Description

The discussion centers on the unique considerations and challenges of treating acne in individuals with skin of color. Research indicates that acne prevalence is slightly higher among these populations, with various factors influencing this disparity including genetic predispositions, inflammatory responses, and cultural practices. Genetic studies suggest variations in specific genes, such as interleukin polymorphisms, may influence acne severity across diverse ethnicities. Clinicians have noted that individuals with skin of color often experience more significant post-inflammatory hyperpigmentation, which can affect treatment satisfaction. Furthermore, disparities in healthcare access result in underdiagnosis and undertreatment for these patients, especially concerning medications like isotretinoin. Effective treatment approaches include targeted use of retinoids, chemical peels, and microneedling, with a focus on minimizing the risk of hyperpigmentation. The challenge of hypertrophic scarring is also emphasized, highlighting the need for early interventions. Overall, addressing the specific issues faced by patients with skin of color is essential for effective acne management and improving patient outcomes.

View more

Conclusions

  • The prevalence of acne is higher among individuals with skin of color compared to other races.
  • African American patients are less likely to receive an acne diagnosis and appropriate treatment compared to white patients.
  • There is a significant association between genetic factors and the predisposition to acne in different ethnic groups.
  • Patients with skin of color may experience more severe inflammatory responses to acne.
  • Cultural practices, such as certain hair care practices, can exacerbate acne in patients with skin of color.
  • Acne-induced macular hyperpigmentation is a significant concern for patients with skin of color and can impact their quality of life.
  • There is a need for greater representation of patients with skin of color in clinical trials for acne treatments.
  • Treatment options like topical retinoids and chemical peels can effectively reduce hyperpigmentation in patients with skin of color.
  • Timely intervention in treating acne in patients with skin of color is crucial to prevent post-inflammatory hyperpigmentation and hypertrophic scarring.
  • Perkins, A C et al. JEADV. 2011.
  • Sobjanek et al, 2011.
  • Ibrahim et al, 2019.
  • Younis & Javed, 2015.
  • Chen et al, 2022.
  • Zhang, H ., & Zhang, Z. Int J Gen Med. 2023.
  • Davis EC, et al. JCAD. 2010.
  • Shareef SJ, et al. JAAD Int. 2024.
  • Rogers, AT, et al. J Dermatolog Treat. 2018.
  • Alexis, A ., et al. Int J Dermatol. 2024.
  • Gorelick, J. JDNA. 2015.
  • Callender, V. JCAD. 2014.
  • Swearingen, A, et al. JAAD. 2025.
  • Olugbade ID, et al. JCD.2025.
  • Gupta, N, et al. J Dtsch Dermatol Ges. 2020
  • Xu, W ., et al. Burns Trauma. 2024.
  • Roggenkamp D, et al. Int J Cosmet Sci. 2021;43(3):292-301.